oxazolidin-2-one has been researched along with Cross Infection in 180 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.56) | 18.2507 |
| 2000's | 103 (57.22) | 29.6817 |
| 2010's | 75 (41.67) | 24.3611 |
| 2020's | 1 (0.56) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SJ; Choi, YJ; Kim, ES; Kim, HB; Kwon, K; Moon, SM; Park, JS; Park, KU; Song, KH | 1 |
| Dupont, J; Prat, D; Sztrymf, B | 1 |
| Dilek, AR; Freitas, AR; Novais, C; Peixe, L | 1 |
| Bassetti, M; Carnelutti, A; Righi, E | 1 |
| Chen, Y; Liu, LL; Qu, TT; Wang, HP; Yang, Q; Yang, XJ; Yu, YS | 1 |
| Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
| Jiang, H; Tang, RN; Wang, J | 1 |
| Rutala, WA; Weber, DJ | 1 |
| Baos, E; Candel, FJ; Merino, P; Pena, I; Picazo, JJ | 1 |
| Barreto, JN; Huang, DB; Morrow, LE; Puzniak, LA | 1 |
| Chavanet, P | 1 |
| Kett, DH; Puttagunta, S; Quartin, AA; Scerpella, EG | 1 |
| Presutti, RJ; Roberts, PF; Sastre, A | 1 |
| Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
| Muscedere, J | 1 |
| Dumitrescu, O; Lina, G | 1 |
| Blasi, F; Chastre, J; Masterton, RG; Rello, J; Torres, A; Welte, T | 1 |
| Awad, SS; Chuang, YC; Engelhardt, M; Marjanek, Z; Pareigis, AJ; Reis, G; Rodriguez, AH; Sánchez, AS; Saulay, M; Scheeren, TW; Zhou, X | 1 |
| Barros, M; Branquinho, R; Grosso, F; Novais, C; Peixe, L | 1 |
| Batista, ML; Hart, M; Medell, M | 1 |
| Charbonneau, C; Chastre, J; Gao, X; Nathwani, D; Niederman, M; Patel, DA; Shorr, AF; Simor, A; Stephens, JM | 1 |
| Dong, W; Dong, Y; He, H; Wang, T; Wang, Y; Xie, J; Xing, J; Zheng, X; Zou, Y | 1 |
| Hickerson, WL; Hill, DM; Wood, GC | 1 |
| Cai, J; Gu, D; Li, Y; Liao, K; Lv, H; Schwarz, S; Shen, J; Wang, X; Wang, Y; Yu, S; Zhang, R; Zhao, K | 1 |
| Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
| Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF | 1 |
| Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X | 1 |
| Babinchak, T; Beuran, M; Bochan, M; Cooper, CA; Dartois, N; Dimov, R; Dukart, G; Ellis-Grosse, EJ; Fichev, G; Florescu, I; Gandjini, H; Razbadauskas, A | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Watanabe, Y | 1 |
| Alvarez-Escudero, J; Giráldez, JM; Martínez-Lamas, L; Regueiro, BJ; Romero-Jung, PA; Treviño, M | 1 |
| Bouza, E; Croos-Dabrera, RV; Herr, DL; Ijzerman, MM; Knirsch, C; Kunkel, MJ; Ruf, BR; Tack, KJ; Wilcox, MH | 1 |
| Fujita, N; Hamaoka, K; Kato, R; Kokufu, T; Kosaka, T; Shime, N; Sugioka, N | 1 |
| Lam, AP; Wunderink, RG | 1 |
| Chaves, F; Daskalaki, M; Otero, JR; Rodríguez-Aranda, A; Sanz, F; Villar, J | 1 |
| Baker, T; De Cock, E; Duttagupta, S; Hardewig, J; Krueger, WA; Müller, E; Piecyk, A; Reisinger, E; Resch, A; Sorensen, S | 1 |
| Chihara, J; Fukui, R; Honda, K; Ishibashi, K; Ito, W; Kagaya, H; Kayaba, H; Kobayashi, N; Kume, M; Sakurada, N; Sato, K; Takeda, M; Tomita, N; Ueki, S; Watanabe, E | 1 |
| Kaiser, GM; Mathe, Z; Paul, A; Rath, PM; Saner, FH; Treckmann, J; Vernadakis, S | 1 |
| Alvarez, F; Cereijo, E; Latorre, MM; Martínez, H; Oltra, R; Rodríguez, O | 1 |
| Busselo, MS; Cisterna, R; García-Arias, A; Gómez-Gil, R; Gutiérrez-Altés, A; Mingorance, J; Romero-Gómez, MP; Ubeda, MG | 1 |
| Niederman, MS | 1 |
| Rubinstein, E; Vinh, DC | 1 |
| Boquete, T; Guillen, J; Gutierrez, J; Martinez, T; Perez-Lopez, JA; Sorlozano, A; Vindel, A; Yuste, ME | 1 |
| Stein, GE; Wells, EM | 1 |
| Boyeras Navarro, ID; Luna, CM | 1 |
| Anastassiou, ED; Damani, A; Diza, E; Filos, K; Fligou, F; Kanellopoulou, M; Liakopoulos, A; Makris, D; Marangos, M; Papafragas, E; Petinaki, E; Protonotariou, E; Schoina, S; Spiliopoulou, I; Tsiapara, F; Zakynthinos, E | 1 |
| Alvarez-Lerma, F | 1 |
| Leonard, SN; Rybak, MJ; Vidaillac, C | 1 |
| Concia, E | 1 |
| Kocher, S; Müller, W; Resch, B | 1 |
| Fukuchi, K; Hanaki, H; Honda, J; Ikeda-Dantsuji, Y; Kaku, M; Kohno, S; Mikamo, H; Nagura, O; Nakae, T; Niki, Y; Nonomiya, Y; Sakai, F; Suwabe, A; Takesue, Y; Tomono, K; Yanagihara, K; Yanagisawa, C; Yoshida, K | 1 |
| Hermsen, ED; Kalil, AC; Murthy, MH; Neto, FK; Rupp, ME; Sun, J | 1 |
| Appelbaum, PC; Julian, KG; Kosowska-Shick, K; McGhee, PL; Whitener, CJ | 1 |
| Hewett, ML | 1 |
| Ippolito, G; Lauria, FN; Leone, S; Nicastri, E; Wenzel, RP | 1 |
| O'Donnell, MR; Walkey, AJ; Wiener, RS | 1 |
| Aydemir, S; Bacakoğlu, F; Başarık, B; Başoğlu, OK; Korkmaz Ekren, P; Pullukçu, H; Susur, A; Taşbakan, MS | 1 |
| Fu, R; Guan, J; Liang, Y; Liu, H; Qu, W; Ruan, EB; Shao, ZH; Song, J; Wang, GJ; Wang, HQ; Wang, XM; Wu, YH; Xing, LM | 1 |
| Burkhardt, O; Pletz, MW; Welte, T | 1 |
| Chen, Q; Huang, P; Huang, YL; Lin, ZQ | 1 |
| Algarate, S; Castillo, FJ; Duran, E; Luque, P; Sáenz, Y; Seral, C; Torres, C | 1 |
| Adam, HJ; Hoban, DJ; Hussain, Z; Kost, S; Lagacé-Wiens, PR; Mataseje, LF; McCracken, M; Mulvey, MR; Nichol, KA; Thompson, K; Zhanel, GG | 1 |
| Ayestarán, JI; Díaz, P; Gallegos, MC; Garau, M; Iuliana Marinescu, C; Oliver, A; Pareja, A; Pérez, JL; Ruiz de Gopegui, E; Socías, A | 1 |
| Cercenado, E | 1 |
| Beretz, L; Levêque, D; Montserrat, M; Schneider, F | 1 |
| Fajardo Olivares, M; Hidalgo Orozco, R; Robles Marcos, M; Rodríguez Garrido, S; Rodríguez-Vidigal, FF; Vera Tomé, A | 1 |
| Arda, B; Aydemir, S; Bardak, S; Dalbasti, T; Pullukcu, H; Ruksen, M; Sipahi, OR; Turhan, T; Ulusoy, S; Yurtseven, T; Zileli, M | 1 |
| Karabekos, D; Karvouniaris, M; Makris, D; Zakynthinos, E | 1 |
| Avazashvili, N; Chikviladze, D; Gachechiladze, Kh; Metreveli, D; Mikeladze, M; Nozadze, T | 1 |
| Cobos, N; Fernandez, J; Martínez, JA; Mensa, J; Mohamad, AM; Morata, L; Soriano, A; Sterzik, H | 1 |
| Gomi, K; Goto, H; Ikeda, H; Izumi, S; Kikuchi, T; Kuroki, J; Maemondo, M; Miki, H; Mitsutake, K; Soma, K; Ueda, Y; Wada, H; Watanabe, A; Yokoyama, T | 1 |
| Cesur, S; Demiröz, AP; Irmak, H; Karakoç, E; Kınıklı, S; Pelitli, TS | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Vorob'eva, TIu | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
| de Almeida, LM; de Araújo, MR; Lincopan, N; Mamizuka, EM | 2 |
| Torres, A | 1 |
| Baruch, A; Chastre, J; Kollef, MH; Kunkel, MJ; McGee, WT; Niederman, MS; Reisman, A; Shorr, AF; Wunderink, RG | 1 |
| Alcalá, L; Bouza, E; Giannella, M; Marin, M; Muñoz, P; Pedromingo, M; Peláez, T; Valerio, M | 1 |
| Denis, O; Jacobs, F; Taccone, FS; Vincent, JL | 1 |
| Charles, PG; Grayson, ML; Howden, BP | 1 |
| Mourvillier, B; Wolff, M | 1 |
| Iwata, K; Masuta, K; Oba, Y | 1 |
| Lahey, T | 1 |
| Dimitroulia, E; Kristo, I; Labrou, M; Makris, D; Ntokou, E; Pournaras, S; Stathopoulos, C; Tsakris, A; Vasdeki, A; Zakynthinos, E | 1 |
| Muñoz-Sanz, A; Nogales-Muñoz, N; Rodríguez-Vidigal, FF; Vera-Tomé, A | 1 |
| Niki, Y | 1 |
| Thamlikitkul, V; Tongsai, S | 1 |
| Anastassiou, ED; Petinaki, E; Spiliopoulou, I | 1 |
| Bourgeois-Nicolaos, N; Decousser, JW; Defrance, G; Derouin, V; Doucet-Populaire, F; Garnier, F; Ichai, P; Levesque, E; Mihaila, L | 1 |
| Alaniz, C; Pogue, JM | 1 |
| Deshpande, LM; Farrell, DJ; Jones, RN; Mendes, RE; Shopsin, B; Smyth, DS | 1 |
| Diomedi, A | 1 |
| Klare, I; Wendt, C; Werner, G; Witte, W | 1 |
| Atalay, S; Ece, G; Köse, I; Köse, S; Maraş, G; Samlıoğlu, P | 1 |
| Church, TJ; Segarra-Newnham, M | 1 |
| Allerberger, FJ; Asboth, F; Johnson, AP; Kaufmann, ME; Livermore, DM; Stockdale, MV; Tysall, L; Warner, M; Woodford, N | 1 |
| Al-Sweih, N; Chugh, TD; Phillips, OA; Udo, EE | 1 |
| Larive, LL; Nguyen, CM; Rhoney, DH | 1 |
| Wilson, SE | 1 |
| Fişenk, I; Günalp, A; Hasçelik, G; Köseoğlu, O; Sener, B | 1 |
| Gouin, F | 1 |
| Cammarata, S; Hafkin, B; Isturiz, R; Le, V; Oliphant, TH; Remington, J; Rubinstein, E; Smith, LG; Standiford, HC | 1 |
| Gold, HS; Inglima, K; Pillai, SK; Press, RA; Rahim, S; Venkataraman, L | 1 |
| Cammarata, SK; Kollef, MH; Oliphant, TH; Wunderink, RG | 1 |
| Adler, S; Bruss, JB; Deville, JG; Edge-Padbury, B; Kaplan, SL; Morfin, MR; Naberhuis-Stehouwer, S; Wu, E; Yogev, R | 1 |
| Adler, S; Bruss, JB; Deville, J; Edge-Padbury, B; Jantausch, BA; Lopez, P; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
| Bruss, JB; Edge-Padbury, B; Goldfarb, J; Kaplan, SA; Naberhuis-Stehouwer, S; Saiman, L; Wible, K | 1 |
| Mankin, AS; Quinn, JP; Ruggero, KA; Schreckenberger, PC; Schroeder, LK | 1 |
| Alexiou-Daniel, S; Bisiklis, A; Chatzidimitriou, M; Kollaras, P; Koumentaki, E; Metallidis, S; Nikolaidis, P; Tsiakiri, E; Tsona, A | 1 |
| Bauer, TT | 1 |
| Cammarata, SK; Croos-Dabrera, RV; Kollef, MH; Rello, J; Wunderink, RG | 2 |
| Cammarata, SK; Kuter, DJ; Le, VH; Nasraway, SA; O'Grady, N; Shorr, AF | 1 |
| Cepeda, JA; Cooper, B; Hails, J; Hayman, S; Jones, K; Kibbler, C; Kwaku, F; Shaw, S; Shulman, R; Singer, M; Taylor, L; Whitehouse, T; Wilson, AP | 1 |
| Beloborodova, NV; Galina, DKh; Kochladze, NG; Kuznetsova, ST; Vostrikova, TIu | 1 |
| Ioanas, M; Lode, H | 1 |
| Bodmann, KF | 1 |
| Rollins, G | 1 |
| Buchanan, LV; Dailey, CF; Gibson, JK; Haas, JV; Pagano, PJ; Van Enk, RA | 1 |
| Kalil, AC; Puumala, SE; Stoner, J | 1 |
| Lin, D; Powers, JH; Ross, DB; Soreth, J | 1 |
| Boldt, J; Papsdorf, M | 1 |
| Wegner, DL | 1 |
| Cunát, V; Janota, J; Jedlicková, A; Kucera, J; Melichar, J; Mikolágová, B; Miletín, J; Stranák, Z | 1 |
| Segreti, J | 1 |
| Lehn, N; Naber, KG; Wagenlehner, FM; Witte, W | 1 |
| Allaouchiche, B; Boselli, E; Breilh, D; Chassard, D; Djabarouti, S; Rimmelé, T; Saux, MC; Toutain, J | 1 |
| Lipman, J | 1 |
| Chiodo, F; Frank, G; Manfredi, R; Sabbatani, S | 1 |
| Arns, Cda C; Follador, W; Guerra, A; Machado, AR | 1 |
| Borgmann, S; Eigner, U; Fahr, AM; Jonas, D; Kettlitz, C; Klare, I; Konstabel, C; Mueller-Bertling, S; Schulte, B; Serr, A; Strommenger, B; Werner, G; Witte, W | 1 |
| Bonora, MG; Catania, MR; Fontana, R; Luzzani, A; Solbiati, M; Stepan, E; Zorzi, A | 1 |
| Stiefelhagen, P | 1 |
| Bertha, G; Grisold, A; Krause, R; Laferl, H; Smolle, KH; Szell, M; Wenisch, C | 1 |
| Altobelli, G; Belfiori, B; Malincarne, L; Marroni, M; Papili, R; Stagni, G; Tinca, M | 1 |
| Huang, J; Malczynski, M; Noskin, GA; Postelnick, MJ; Qi, C; Scheetz, MH; Warren, JR; Zembower, TR | 1 |
| Dobbs, TE; Hoesley, CJ; Moser, SA; Patel, M; Stamm, AM; Waites, KB | 1 |
| Daniel Mullins, C; Kuznik, A; Levine, AR; Liu, LZ; Obeidat, NA; Shaya, FT; Wong, W | 1 |
| Scheinfeld, N | 1 |
| Abb, J | 1 |
| Chatzis, N; Fanourgiakis, P; Golfinopoulou, S; Mylona, E; Platsouka, E; Skoutelis, A; Vryonis, E | 1 |
| Ariza, A; Azmi, S; Zubaidah, AW | 1 |
| Cuzzolin, L; Fanos, V | 1 |
| Hall, RG; Maclayton, DO | 1 |
| Sunakawa, K | 1 |
| Marik, PE; Salerno, D; Vahid, B | 1 |
| Estes, L; Orenstein, R | 1 |
| Lyles, A | 1 |
| Estes, L; Orenstem, R | 1 |
| Kessler, AT; Kourtis, AP | 1 |
| Darini, AL; Freitas, C; Gontijo Filho, PP; Moreira, TA; Ribas, RM | 1 |
| Pasculle, AW; Paterson, DL; Pogue, JM; Potoski, BA | 1 |
| Chi, CY; Lauderdale, TL; Liu, CC; Wang, SM; Wu, JM; Yang, YJ | 1 |
| Linden, PK | 1 |
| Arias, CA; Castañeda, E; Moreno, J; Murray, BE; Panesso, D; Quinn, JP; Reyes, J; Vallejo, M; Villegas, MV | 1 |
| Aydemir, S; Cilli, F; Pullukcu, H; Sipahi, OR; Tasbakan, M; Turhan, A; Ulusoy, S | 1 |
| Broyles, J; Chow, S; Craig, AS; Devasia, RA; Jones, TF; Kainer, MA; Melton, K; Moore, KL; Schaffner, W; Simmons, BP | 1 |
| Burkhardt, O; Mertgen, CP; Pletz, MW; Welte, T | 1 |
| Collins, J; Donnelly, M; Flanagan, M; Gowing, C; Kelly, S; Maguire, M; Murphy, PG | 1 |
| Danese, P; DeVito, J; Franceschi, F; Lawrence, L; Sutcliffe, J | 1 |
| Kollef, MH; Nathwani, D; Rubinstein, E | 1 |
| Akcam, FZ; Kaya, O; Temel, EN | 1 |
| Barbachyn, MR; Ford, CW; Hamel, JC; Hutchinson, DK; Moerman, JK; Stapert, D; Zurenko, GE | 1 |
| Johnson, AP; Livermore, DM; Warner, M | 1 |
| Batts, DH | 1 |
| Plouffe, JF | 1 |
| Cammarata, S; Oliphant, T; Rubinstein, E; Wunderink, R | 1 |
| Fung, HB; Kirschenbaum, HL; Ojofeitimi, BO | 1 |
| Norrby, R | 1 |
| Stephenson, J | 1 |
| Batts, DH; Eliopoulos, GM; Lavin, BS | 1 |
| Gales, AC; Jones, RN; Sader, HS | 1 |
| Herrero, IA; Issa, NC; Patel, R | 1 |
| Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
| Johnson, AP; Livermore, DM; Tillotson, GS | 1 |
| Nathwani, D | 1 |
| Krueger, WA; Unertl, KE | 1 |
| Pertel, PE; Till, M; Wixson, RL | 1 |
| Rehm, SJ | 1 |
| Chuchalin, AG; Fesenko, OV; Fomina, IG; Grudinina, SA; Krotova, LA; Kurdiukova, IuP; Kutsenko, MA; Marinin, VF; Sidorenko, SV; Sinpal'nikov, AI; Solomatin, AS; Sterkhova, GV; Zubkov, MM | 1 |
41 review(s) available for oxazolidin-2-one and Cross Infection
| Article | Year |
|---|---|
Current role of oxazolidinones and lipoglycopeptides in skin and soft tissue infections.
Topics: Administration, Intravenous; Administration, Oral; Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Humans; Lipoglycopeptides; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Teicoplanin; Tetrazoles | 2019 |
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Staphylococcal Infections; Teicoplanin; Vancomycin | 2013 |
New antibiotic agents: problems and prospects.
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pseudomonas aeruginosa; Surgical Wound Infection; Tigecycline; Vancomycin Resistance | 2005 |
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Europe; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Risk Factors; Vancomycin | 2014 |
Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Health care-associated pneumonia: identification and initial management in the ED.
Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline | 2008 |
The role of MRSA in healthcare-associated pneumonia.
Topics: Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Risk Factors; Staphylococcal Infections; Virulence | 2009 |
Treatment options for nosocomial pneumonia due to MRSA.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Vancomycin | 2009 |
Linezolid: a review of safety and tolerability.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Interactions; Drug Tolerance; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Monoamine Oxidase Inhibitors; Oxazolidinones; Pneumonia, Bacterial; Selective Serotonin Reuptake Inhibitors | 2009 |
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Management of methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Incidence; Infusions, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2010 |
[Therapy of SSTI and role of tigecycline].
Topics: Acetamides; Anti-Bacterial Agents; Combined Modality Therapy; Comorbidity; Cross Infection; Daptomycin; Debridement; Drainage; Drug Therapy, Combination; Humans; Italy; Linezolid; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections; Tigecycline; Wound Infection | 2009 |
Linezolid treatment of nosocomial bacterial infection with multiresistant Gram-positive pathogens in preterm infants: a systematic review.
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Clinical Trials as Topic; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Injections, Intravenous; Linezolid; Oxazolidinones; United States | 2010 |
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Education, Medical, Continuing; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Randomized Controlled Trials as Topic; Renal Insufficiency; Teicoplanin; Thrombocytopenia; Vancomycin | 2010 |
Methicillin-resistant Staphylococcus aureus: the superbug.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Cross Infection; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Treatment Outcome | 2010 |
Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Glycopeptides; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic | 2011 |
Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2010 |
[Linezolid versus vancomycin in the treatment of pneumonia caused by Gram-positive cocci: meta-analysis of randomised controlled trials].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Cocci; Humans; Linezolid; Oxazolidinones; Pneumonia, Pneumococcal; Randomized Controlled Trials as Topic; Vancomycin | 2010 |
[Update of antimicrobial resistance in Gram-positive microorganisms].
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterococcus; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; United States; Vancomycin | 2010 |
Nosocomial MRSA pneumonia: data from recent clinical trials.
Topics: Acetamides; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cross Infection; DNA, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Vancomycin | 2011 |
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2012 |
Linezolid: implications for neurosurgical infections.
Topics: Acetamides; Animals; Anti-Infective Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Neurosurgical Procedures; Oxazolidinones | 2003 |
Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and postoperative gram-positive infections.
Topics: Acetamides; Anti-Infective Agents; Clinical Trials as Topic; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Surgical Wound Infection | 2001 |
[Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Infectious; Soft Tissue Infections | 2004 |
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.
Topics: Acetamides; Ampicillin Resistance; Anti-Infective Agents; Bacterial Proteins; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Germany; Gram-Positive Bacterial Infections; Humans; Hyaluronoglucosaminidase; Linezolid; Membrane Proteins; Oxazolidinones; Phenotype; Phylogeny; Polymerase Chain Reaction; Vancomycin Resistance | 2005 |
Dalbavancin: a review for dermatologists.
Topics: Acetamides; Adult; Animals; Catheterization; Clinical Trials, Phase III as Topic; Cross Infection; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Fever; Gram-Positive Bacterial Infections; Headache; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2006 |
Linezolid: a new antibiotic for newborns and children?
Topics: Acetamides; Anti-Infective Agents; Bacterial Infections; Child; Child, Preschool; Cross Infection; Humans; Infant; Infant, Newborn; Linezolid; Oxazolidinones; Treatment Outcome | 2006 |
Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; MEDLINE; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2007 |
Optimizing therapy for vancomycin-resistant enterococci (VRE).
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2007 |
Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Drug Interactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Patents as Topic; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Oxazolidinones: new antibacterial agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Community-Acquired Infections; Cross Infection; Humans; Oxazoles; Oxazolidinones; Penicillin Resistance | 1997 |
Linezolid--a new option for treating gram-positive infections.
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Linezolid; Outpatients; Oxazolidinones; Staphylococcal Infections; Vancomycin Resistance | 2000 |
Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2000 |
Linezolid: an oxazolidinone antimicrobial agent.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Drug Interactions; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Soft Tissue Infections; Vancomycin Resistance | 2001 |
Linezolid--a review of the first oxazolidinone.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Biological Availability; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cross Infection; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Child; Cross Infection; Drug Combinations; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Tissue Distribution; Virginiamycin | 2001 |
Antimicrobial susceptibility of Gram-positive bacteria: what's current, what's anticipated?
Topics: Acetamides; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Cross Infection; Drug Resistance, Bacterial; Drugs, Investigational; Europe; Gram-Positive Bacterial Infections; Humans; Infection Control; Linezolid; Oxazolidinones; Practice Patterns, Physicians'; United States; Virginiamycin | 2001 |
[New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
Topics: Acetamides; Anti-Bacterial Agents; Critical Illness; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2002 |
Two new treatment options for infections due to drug-resistant gram-positive cocci.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Methicillin; Oxazolidinones; Virginiamycin | 2002 |
19 trial(s) available for oxazolidin-2-one and Cross Infection
| Article | Year |
|---|---|
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Body Weight; Cross Infection; Dose-Response Relationship, Drug; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2013 |
The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Humans; Kidney Diseases; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2013 |
A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Cross Infection; Demography; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; Vancomycin | 2013 |
A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia.
Topics: Acetamides; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Therapy; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Young Adult | 2014 |
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Vancomycin | 2014 |
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2008 |
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2008 |
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Vancomycin | 2009 |
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cross Infection; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome | 2012 |
Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; DNA, Bacterial; Double-Blind Method; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Staphylococcal Protein A; United States; Vancomycin | 2012 |
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2003 |
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Topics: Acetamides; Bacteremia; Child; Child, Preschool; Confidence Intervals; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Female; Follow-Up Studies; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Latin America; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Probability; Severity of Illness Index; Treatment Outcome; United States; Vancomycin | 2003 |
Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Safety and tolerability of linezolid in children.
Topics: Acetamides; Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefadroxil; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Gram-Positive Bacterial Infections; Headache; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Multicenter Studies as Topic; Otitis Media; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Skin Diseases, Bacterial | 2003 |
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Thrombocytopenia; Vancomycin | 2003 |
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Critical Care; Critical Illness; Cross Infection; Double-Blind Method; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Pneumonia, Bacterial; Respiratory Tract Infections; Sepsis; Soft Tissue Infections; Teicoplanin; Treatment Outcome | 2004 |
[Linezolid for the treatment of nosocomial infections after cardiac surgery].
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Cardiac Surgical Procedures; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Infant; Injections, Intravenous; Linezolid; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia; Postoperative Complications; Staphylococcus; Surgical Wound Infection; Treatment Outcome | 2003 |
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Cross Infection; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacteria; Hospitalization; Humans; Linezolid; Male; Middle Aged; Monobactams; Oxazolidinones; Pneumonia; Safety; Time Factors; Treatment Outcome; Vancomycin | 2001 |
[Comparison of linezolid and vancomycin in nosocomial pneumonia: results of the multicenter double-blind study].
Topics: Acetamides; Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Cross Infection; Double-Blind Method; Drug Resistance, Bacterial; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial | 2002 |
120 other study(ies) available for oxazolidin-2-one and Cross Infection
| Article | Year |
|---|---|
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Staphylococcal Infections | 2023 |
Linezolid versus vancomycin in Methicillin Resistant Staphylococcus aureus nosocomial pneumonia in the elderly.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2017 |
Dissemination of Staphylococcus epidermidis ST22 With Stable, High-Level Resistance to Linezolid and Tedizolid in the Greek-Turkish Region (2008-2016).
Topics: Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Fatal Outcome; Genes, Bacterial; Humans; Linezolid; Male; Multiple Organ Failure; Mutation; Oxazolidinones; Staphylococcal Infections; Staphylococcus epidermidis; Tetrazoles; Turkey | 2018 |
Emergence of cfr-harbouring coagulase-negative staphylococci among patients receiving linezolid therapy in two hospitals in China.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Proteins; China; Coagulase; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Oxazolidinones; Plasmids; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Staphylococcus hominis | 2013 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolid-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Disease Outbreaks; DNA Mutational Analysis; Drug Resistance, Bacterial; Humans; Intensive Care Units; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Point Mutation; Ribosomal Protein L3; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2013 |
A practical guide to community-acquired MRSA.
Topics: Acetamides; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Continuity of Patient Care; Cross Infection; Ethnicity; Humans; Linezolid; Medical History Taking; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Oxazolidinones; Patient Education as Topic; Physical Examination; Practice Guidelines as Topic; Rifampin; Risk Factors; Secondary Prevention; Skin; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2014 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
What is the place of linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia and complicated skin and soft tissue infections in Europe?
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Europe; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Soft Tissue Infections; Staphylococcal Skin Infections | 2014 |
Linezolid-Resistant Staphylococcus epidermidis, Portugal, 2012.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Oxazolidinones; Portugal; Staphylococcal Infections; Staphylococcus epidermidis | 2014 |
[In vitro antimicrobial susceptibility in Enterococcus faecalis and Enterococcus faecium isolated from hospitalized patients].
Topics: Acetamides; Bacterial Typing Techniques; Cross Infection; Cuba; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Tertiary Care Centers; Vancomycin Resistance | 2014 |
Linezolid bladder irrigation as adjunctive treatment for a vancomycin-resistant Enterococcus faecium catheter-associated urinary tract infection.
Topics: Acetamides; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Therapeutic Irrigation; Urinary Bladder; Urinary Tract Infections; Vancomycin Resistance | 2015 |
Enterococcal isolates carrying the novel oxazolidinone resistance gene optrA from hospitals in Zhejiang, Guangdong, and Henan, China, 2010-2014.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; China; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Genes, Bacterial; Hospitals; Humans; Male; Middle Aged; Multilocus Sequence Typing; Oxazolidinones; Young Adult | 2015 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Improved antimicrobial activity of linezolid against vancomycin-intermediate Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit.
Topics: Acetamides; Anti-Bacterial Agents; Cluster Analysis; Critical Illness; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Drug Utilization; Female; Genotype; Humans; Intensive Care Units; Linezolid; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus epidermidis | 2009 |
Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Child, Preschool; Cross Infection; Female; Humans; Infant; Injections, Intravenous; Linezolid; Male; Mediastinitis; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Plasma; Staphylococcal Infections; Surgical Wound Infection | 2009 |
Nosocomial spread of linezolid-resistant Staphylococcus haemolyticus infections in an intensive care unit.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Catheterization; Cluster Analysis; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Staphylococcal Infections; Staphylococcus haemolyticus; Teicoplanin | 2009 |
Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Drug Costs; Female; Germany; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Oxazolidinones; Pneumonia, Staphylococcal; Retrospective Studies; Vancomycin | 2009 |
Clinical evaluation after a notification policy of linezolid use: a case series of 22 patients.
Topics: Acetamides; Aged; Anti-Infective Agents; Cross Infection; Drug and Narcotic Control; Female; Humans; Infection Control; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Staphylococcal Infections | 2009 |
Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cross Infection; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Liver Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Salvage Therapy; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2009 |
Use of linezolid in critically ill patients admitted to intensive care units.
Topics: Acetamides; Anti-Bacterial Agents; Catheter-Related Infections; Community-Acquired Infections; Critical Care; Critical Illness; Cross Infection; Disease Susceptibility; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Postoperative Complications; Prospective Studies; Staphylococcal Infections; Thrombocytopenia; Treatment Outcome | 2009 |
Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Spain; Young Adult | 2009 |
Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Blood; Cross Infection; DNA Mutational Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Glycopeptides; Humans; Intensive Care Units; Linezolid; Microbial Sensitivity Tests; Mutation, Missense; Oxazolidinones; RNA, Bacterial; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus hominis | 2010 |
Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Cluster Analysis; Cross Infection; DNA Fingerprinting; Drug Resistance, Bacterial; Genotype; Greece; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Oxazolidinones; Point Mutation; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus epidermidis; Young Adult | 2010 |
[Linezolid in the treatment of gram positive coccal infections in critical patients].
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Critical Care; Critical Illness; Cross Infection; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Oxazolidinones | 2010 |
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin | 2010 |
Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Japan; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Staphylococcal Infections | 2011 |
Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Oxazolidinones; RNA, Ribosomal, 23S; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis | 2010 |
What is MRSA?
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2010 |
[Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Anti-Infective Agents; APACHE; Cross Infection; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Respiratory Care Units; Retrospective Studies; Teicoplanin | 2010 |
[Clinical analysis of 102 blood disease patients with gram positive cocci infection treated with Linezolid].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Diseases; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus | 2010 |
Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Catheter-Related Infections; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Intensive Care Units; Linezolid; Male; Methicillin; Molecular Typing; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Spain; Staphylococcal Infections; Staphylococcus epidermidis | 2011 |
Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Canada; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Daptomycin; DNA, Bacterial; Drug Resistance, Bacterial; Exotoxins; Female; Hospitals; Humans; Infant; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin Resistance | 2011 |
[Nosocomial spread of linezolid-resistant Staphylococcus hominis in two hospitals in Majorca].
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Linezolid; Male; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus hominis | 2011 |
[Linezolid use in an intensive care unit].
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Utilization; Female; France; Gram-Positive Bacterial Infections; Guideline Adherence; Hospitals, University; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Practice Guidelines as Topic; Retrospective Studies | 2011 |
Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Topics: Acetamides; Bacteremia; Catheter-Related Infections; Ciprofloxacin; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Hospital Departments; Hospitals, University; Humans; Length of Stay; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Staphylococcus hominis; Vancomycin | 2011 |
Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Female; Humans; Linezolid; Male; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Neurosurgical Procedures; Oxazolidinones; Postoperative Complications; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections | 2011 |
[Microbial spectrum of nosocomial pneumonia in traumatological patients].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Female; Hospitals; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Wounds and Injuries | 2011 |
Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Comorbidity; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Renal Insufficiency; Retrospective Studies; Risk Factors; Vancomycin | 2011 |
Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: a prospective observational study.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cross Infection; Female; Humans; Japan; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
[Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin | 2011 |
[Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Candida; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infection Control; Intensive Care Units; Linezolid; Meropenem; Moscow; Oxazolidinones; Sepsis; Thienamycins; Vancomycin | 2011 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
Dissemination of the linezolid-resistant Staphylococcus epidermidis clone ST2 exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary-care hospital, Brazil.
Topics: Acetamides; Anti-Bacterial Agents; Brazil; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Staphylococcal Infections; Staphylococcus epidermidis | 2012 |
Antibiotic treatment against methicillin-resistant Staphylococcus aureus hospital- and ventilator-acquired pneumonia: a step forward but the battle continues.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal | 2012 |
Clonal dissemination of linezolid-resistant Staphylococcus haemolyticus exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary care hospital in Brazil.
Topics: Acetamides; Anti-Bacterial Agents; Brazil; Catheter-Related Infections; Catheters; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Oxazolidinones; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus haemolyticus | 2012 |
Potential protective role of linezolid against Clostridium difficile infection.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Diarrhea; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Spain; Treatment Outcome | 2012 |
Should we abandon vancomycin for treatment of methicillin-resistant Staphylococcus aureus pneumonia? Still questions to answer.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal | 2012 |
A potential "blind spot" in vancomycin treatment studies.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal | 2012 |
Linezolid for the treatment of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal | 2012 |
Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: controversy continues.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal | 2012 |
Questionable superiority of linezolid for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: watch where you step.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal | 2012 |
Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Greece; Hospitals, University; Humans; Intensive Care Units; Linezolid; Molecular Epidemiology; Molecular Typing; Oxazolidinones; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2012 |
[Linezolid, coagulase-negative Staphylococcus and the problem of resistances].
Topics: Acetamides; Aged; Coagulase; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospital Departments; Hospital Mortality; Humans; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus | 2012 |
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal | 2012 |
Comment on: Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Topics: Acetamides; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Molecular Typing; Oxazolidinones | 2012 |
A dual outbreak of bloodstream infections with linezolid-resistant Staphylococcus epidermidis and Staphylococcus pettenkoferi in a liver Intensive Care Unit.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Oxazolidinones; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus | 2012 |
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2012 |
[In Process Citation].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal | 2012 |
[Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance].
Topics: Acetamides; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Population Surveillance; Serotyping; Teicoplanin; Vancomycin Resistance | 2012 |
[Evaluation of vancomycin-resistant Enterococcus cases at a tertiary level hospital in Izmir, Turkey].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Culture Media; Daptomycin; Enterococcus; Environmental Microbiology; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Turkey; Vancomycin Resistance; Young Adult | 2012 |
Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Austria; Base Sequence; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Oxazolidinones; Polymerase Chain Reaction; Sensitivity and Specificity | 2002 |
Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals.
Topics: Acetamides; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Kuwait; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Polymerase Chain Reaction; Prevalence; Vancomycin Resistance | 2003 |
[Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Humans; Lincosamides; Macrolides; Oxazolidinones; Pneumococcal Infections; Streptococcus pneumoniae; Streptogramins | 2002 |
[Contribution of linezolid to the treatment of nosocomial pneumonia].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cross Infection; Drug Interactions; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Multicenter Studies as Topic; Oxazolidinones; Protein Synthesis Inhibitors | 2003 |
Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
Topics: Acetamides; Aged; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Vancomycin; Vancomycin Resistance | 2003 |
Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs.
Topics: Acetamides; Aged; Base Sequence; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterococcus faecalis; Genes, Bacterial; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazolidinones; Polymerase Chain Reaction; Stroke | 2003 |
Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; In Vitro Techniques; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin Resistance | 2003 |
Nosocomial pneumonia: therapy is just not good enough.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2003 |
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Regression Analysis; Vancomycin | 2003 |
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Logistic Models; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Survival Analysis; Survival Rate; Vancomycin | 2004 |
Linezolid in VAP by MRSA: a better choice?
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Respiration, Artificial; Vancomycin | 2004 |
Linezolid better than vancomycin in treating drug-resistant pneumonia.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2004 |
Effects of linezolid on staphylococcal adherence versus time of treatment.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Cross Infection; Humans; In Vitro Techniques; Linezolid; Microscopy, Electron, Scanning; Oxazolidinones; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Vancomycin | 2004 |
Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia.
Topics: Acetamides; Cross Infection; Female; Follow-Up Studies; Humans; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Risk Assessment; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2004 |
Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Vancomycin | 2004 |
[Expensive modern therapy options in intensive care medicine in Germany-- are they being used? Results of a questionnaire].
Topics: Acetamides; Anti-Infective Agents; Critical Care; Cross Infection; Drug Utilization; Factor VIIa; Germany; Hemorrhage; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Protein C; Recombinant Proteins; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Surveys and Questionnaires | 2005 |
No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Liability, Legal; Linezolid; Methicillin Resistance; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2005 |
[The first experience with linezolide in treatment of nosocomial septic condition in premature neonates].
Topics: Acetamides; Anti-Bacterial Agents; Coagulase; Cross Infection; Humans; Infant, Newborn; Infant, Premature, Diseases; Linezolid; Oxazolidinones; Sepsis; Staphylococcal Infections; Staphylococcus | 2004 |
Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2005 |
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Cross Infection; Daptomycin; Enterococcus; Genotype; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Urinary Tract Infections; Vancomycin | 2005 |
Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Cross Infection; Female; Hospitals, University; Humans; Intensive Care Units; Linezolid; Lung; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial; Respiratory Mucosa | 2005 |
Is the end-game penetration (of the airway)?
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Lung; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia, Staphylococcal; Respiration, Artificial | 2005 |
Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Brain Abscess; Brain Neoplasms; Capnocytophaga; Combined Modality Therapy; Craniotomy; Cross Infection; Drainage; Drug Evaluation; Drug Resistance; Epilepsy, Tonic-Clonic; Frontal Lobe; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Mandibular Diseases; Meningitis, Bacterial; Middle Aged; Oligodendroglioma; Osteolysis; Oxazolidinones; Postoperative Complications; Sinusitis | 2005 |
Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Costs; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Respiration, Artificial; Staphylococcus aureus; Vancomycin | 2005 |
Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.
Topics: Acetamides; Alleles; Base Sequence; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Italy; Linezolid; Molecular Epidemiology; Oxazolidinones; RNA, Bacterial; RNA, Ribosomal, 23S; Vancomycin Resistance | 2006 |
[Is your patient MRSA (multi-resistent Staphylococcus aureus) free?].
Topics: Acetamides; Anti-Bacterial Agents; Carrier State; Cross Infection; Drug Resistance, Multiple; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Patient Admission; Preoperative Care; Staphylococcal Skin Infections; Staphylococcus aureus | 2006 |
A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Drug Utilization; Female; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Nosocomial spondylodiskitis with epidural abscess and CSF fistula cured with quinupristin/dalfopristin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Cerebrospinal Fluid; Combined Modality Therapy; Cross Infection; Curettage; Device Removal; Discitis; Epidural Abscess; Female; Fistula; Fluconazole; Fungi; Humans; Internal Fixators; Laminectomy; Linezolid; Lumbar Vertebrae; Meropenem; Methicillin Resistance; Middle Aged; Osteomyelitis; Oxazolidinones; Parkinson Disease; Prosthesis-Related Infections; Reoperation; Skin Diseases; Spinal Diseases; Spinal Stenosis; Staphylococcal Infections; Thienamycins; Virginiamycin | 2006 |
The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Topics: Academic Medical Centers; Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2006 |
Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
Topics: Academic Medical Centers; Acetamides; Adult; Aged; Aged, 80 and over; Alabama; Anti-Infective Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2006 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Female; Health Care Costs; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Staphylococcus aureus; Vancomycin | 2006 |
In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2007 |
Linezolid-based therapy in Staphylococcus epidermidis endocarditis.
Topics: Acetamides; Aged; Anti-Infective Agents; Cross Infection; Endocarditis, Bacterial; Humans; Linezolid; Male; Oxazolidinones; Staphylococcus epidermidis | 2007 |
Hospital-acquired vancomycin-resistant enterococci: now appearing in Kuala Lumpur Hospital.
Topics: Acetamides; Adult; Anti-Infective Agents; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Hospitals; Hospitals, Public; Humans; Kidney Failure, Chronic; Linezolid; Malaysia; Oxazolidinones; Phenotype; Population Surveillance; Time Factors; Vancomycin Resistance | 2006 |
[Appropriate use of anti-MRSA drugs (discussion)].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Dibekacin; Humans; Immunocompromised Host; Linezolid; Methicillin Resistance; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Cross Infection; Female; Humans; Linezolid; Male; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Thoracic Surgical Procedures; Treatment Failure; Treatment Outcome; Vancomycin | 2007 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Dose-Response Relationship, Drug; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Staphylococcus aureus; Survival Rate; Vancomycin | 2007 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Disclosure; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Peer Review, Research; Pneumonia, Staphylococcal; Research Design; Staphylococcus aureus; Vancomycin | 2007 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2007 |
Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid.
Topics: Acetamides; Anesthesia, Epidural; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Infusions, Intravenous; Linezolid; Meningitis, Bacterial; Methicillin Resistance; Middle Aged; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Vancomycin-resistant VanA phenotype Enterococcus faecalis: first case in Minas Gerais state and epidemiological considerations.
Topics: Acetamides; Adult; Anti-Infective Agents; Brazil; Cross Infection; Enterococcus faecalis; Female; Genotype; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Phenotype; Vancomycin Resistance | 2007 |
Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Transmission, Infectious; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Parenteral Nutrition, Total; Peripheral Vascular Diseases; Retrospective Studies; Risk Factors; Transplants; Vancomycin Resistance | 2007 |
Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Child, Preschool; Cross Infection; Endocarditis, Bacterial; Female; Fusidic Acid; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Colombia; Contact Tracing; Cross Infection; Drug Resistance, Bacterial; Family Characteristics; Fatal Outcome; Female; Humans; Linezolid; Methicillin Resistance; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; RNA, Ribosomal, 23S; Staphylococcal Infections; Staphylococcus aureus; Thiamphenicol | 2008 |
In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates.
Topics: Acetamides; Cross Infection; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin Resistance | 2008 |
Response to emerging infection leading to outbreak of linezolid-resistant enterococci.
Topics: Acetamides; Anti-Infective Agents; Case-Control Studies; Colony Count, Microbial; Communicable Diseases, Emerging; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Length of Stay; Linezolid; Microbial Sensitivity Tests; Multivariate Analysis; Oxazolidinones; Vancomycin Resistance | 2007 |
An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Environmental Microbiology; Female; Genotype; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Point Mutation; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus epidermidis | 2008 |
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cross Infection; Enterococcus; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Respiratory System; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2008 |
In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Turkey | 2008 |
Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Streptococcus; Streptococcus pneumoniae; United Kingdom | 2000 |
Researchers describe latest strategies to combat antibiotic-resistant microbes.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Daptomycin; Drug Industry; Drug Resistance, Microbial; Drugs, Investigational; Europe; Humans; Linezolid; Oxazolidinones; Protein Synthesis Inhibitors | 2001 |
Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil.
Topics: Acetamides; Anti-Bacterial Agents; Brazil; Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin Resistance | 2001 |
Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Base Sequence; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Design and Construction; Humans; Linezolid; Liver Transplantation; Molecular Sequence Data; Mutation; Oxazolidinones; Vancomycin Resistance | 2002 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |
Economic impact and formulary positioning of linezolid: a new anti-Gram-positive antimicrobial.
Topics: Acetamides; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Cost-Benefit Analysis; Cross Infection; Drug Resistance, Bacterial; Formularies, Hospital as Topic; Gram-Positive Bacterial Infections; Humans; Infection Control; Linezolid; Methicillin Resistance; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; United States | 2001 |
Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Osteomyelitis; Oxazolidinones; Vancomycin Resistance | 2002 |